AUSTIN, TX – February 8, 2022 – Iodine Software has been named the market leader for CDI Software by KLAS Research in their 2022 Best in KLAS: Software and Services Report. Iodine ranked #1 with a score of 91.2, and this achievement follows AwareCDI™ receiving the top overall performance score in the 2021 KLAS Clinical Documentation Improvement (CDI) Report. In 2021 Iodine Software acquired Chartwise, who was also a top performer in the 2022 KLAS report with a score of 89.2.
The Best in KLAS report recognizes software and services companies who excel at helping healthcare professionals improve patient care. The report noted that 95% of respondents answered “yes,” both Iodine AwareCDI and Chartwise “avoid charging for every little thing” and AwareCDI was “part of long-term plans”. All rankings are a direct result of the feedback of thousands of providers over the last year. “This award reflects our commitment to delivering the most powerful, predictive tools as well as exceptional service and support to every client, working hard to be responsive, timely and proactive to our clients’ unique needs, said William Chan, CEO and co-founder of Iodine. “This Best in KLAS award is especially meaningful because it reflects the positive experiences of our clients.”
Iodine’s AwareCDI solution empowers organizations to scale their most precious and limited resources, their clinical talent, through automation of clinical work that otherwise would require highly trained and specialized staff to complete. Clients report higher productivity and job satisfaction for CDI teams and physicians, complete and accurate documentation, and capturing more earned revenue. The Iodine AwareCDI Suite helps hundreds of hospitals to collectively recognize $1.5 billion1 in additional appropriate reimbursement annually.
According to KLAS Research President Adam Gale, “The Best in KLAS report and the awards it contains set the standard of excellence for software and services firms. The Best in KLAS award serves as a signal to provider and payer organizations that they should expect excellence from the winning vendors.”
To download the full 2022 KLAS Clinical Documentation Improvement Report, visit : https://klasresearch.com/report/2022-best-in-klas-awards-software-and-professional-services/2770
KLAS Research will honor Iodine and the other segment winners for 2022 in a ceremony held at HIMSS March 14th.
About Iodine Software:
Iodine is an enterprise AI company that is championing a radical rethink of how to create value for healthcare professionals, leaders, and their organizations: automating complex clinical tasks, generating insights and empowering intelligent care. Iodine’s powerful predictive engine complements the skills and judgment of healthcare professionals by interpreting raw clinical data to generate real-time, highly focused, predictive insights that clinicians and hospital administrators can leverage to dramatically augment the management of care delivery – facilitating critical decisions, scaling clinical workforces through automation, and improving the financial position of health systems. For more information, please visit iodinesoftware.com.
About KLAS Research:
KLAS has been providing accurate, honest, and impartial insights for the healthcare IT (HIT) industry since 1996. The KLAS mission is to improve the world’s healthcare by amplifying the voice of providers and payers. The scope of our research is constantly expanding to best fit market needs as technology becomes increasingly sophisticated. KLAS finds the hard-to-get HIT data by building strong relationships with our payer and provider friends in the industry. Learn more at klasresearch.com
1. Figures are based on a $6,000 modeled base rate and actual measured MCC capture performance from the 2019 Iodine Performance Cohort Analysis of 339 facilities that compared measured MCC capture and CMI impact for the Iodine usage period 9/1/2018-8/31/2019 against pre-Iodine baseline performance.
